FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Karin Rimvall

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Anatomy

Genes & Molecular Sequences

Molecular Structure

Procedures

Co-author Network

Publications

TOP 3
Kjell Malmlöf; Sven Hastrup; Birgitte S Wulff; Barbara C Hansen; Bernd Peschke; Claus Bekker Jeppesen; Rolf Hohlweg; Karin Rimvall
Antagonistic targeting of the histamine H3 receptor decreases caloric intake in higher mammalian species.
Kjell Malmlöf; Valeria Golozoubova; Bernd Peschke; Birgitte S Wulff; Hanne H F Refsgaard; Peter Bygballe Johansen; Thomas Cremers; Karin Rimvall
Increase of neuronal histamine in obese rats is associated with decreases in body weight and plasma triglycerides.
Jesper F Lau; Claus Bekker Jeppesen; Karin Rimvall; Rolf Hohlweg
Ureas with histamine H3-antagonist receptor activity--a new scaffold discovered by lead-hopping from cinnamic acid amides.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Karin Rimvall (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Kjell Malmlöf; Sven Hastrup; Birgitte S Wulff; Barbara C Hansen; Bernd Peschke; Claus Bekker Jeppesen; Rolf Hohlweg; Karin Rimvall
Antagonistic targeting of the histamine H3 receptor decreases caloric intake in higher mammalian species.
Biochemical pharmacology 2007;73(8):1237-42.
2006: Kjell Malmlöf; Valeria Golozoubova; Bernd Peschke; Birgitte S Wulff; Hanne H F Refsgaard; Peter Bygballe Johansen; Thomas Cremers; Karin Rimvall
Increase of neuronal histamine in obese rats is associated with decreases in body weight and plasma triglycerides.
Obesity (Silver Spring, Md.) 2006;14(12):2154-62.
2006: Jesper F Lau; Claus Bekker Jeppesen; Karin Rimvall; Rolf Hohlweg
Ureas with histamine H3-antagonist receptor activity--a new scaffold discovered by lead-hopping from cinnamic acid amides.
Bioorganic & medicinal chemistry letters 2006;16(20):5303-8.
2006: Bernd Peschke; Sonja Bak; Rolf Hohlweg; Rita Nielsen; Dorthe Viuff; Karin Rimvall
Benzo[b]thiophene-2-carboxamides and benzo[b]furan-2-carboxamides are potent antagonists of the human H3-receptor.
Bioorganic & medicinal chemistry letters 2006;16(12):3162-5.
2005: Kjell Malmlöf; Florencio Zaragoza; Valeria Golozoubova; Hanne H F Refsgaard; T Cremers; Kirsten Raun; Birgitte S Wulff; Peter Bygballe Johansen; B Westerink; Karin Rimvall
Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight.
International journal of obesity (2005) 2005;29(12):1402-12.
2005: Florencio Zaragoza; Henrik Stephensen; Bernd Peschke; Karin Rimvall
2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.
Journal of medicinal chemistry 2005;48(1):306-11.
2004: Florencio Zaragoza; Henrik Stephensen; Sanne M Knudsen; Lone Pridal; Birgitte S Wulff; Karin Rimvall
1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.
Journal of medicinal chemistry 2004;47(11):2833-8.
2004: Bernd Peschke; Sonja Bak; Rolf Hohlweg; Ingrid Pettersson; Hanne H F Refsgaard; Dorthe Viuff; Karin Rimvall
Cinnamic amides of (S)-2-(aminomethyl)pyrrolidines are potent H3 antagonists.
Bioorganic & medicinal chemistry 2004;12(10):2603-16.
2002: Birgitte S Wulff; Sven Hastrup; Karin Rimvall
Characteristics of recombinantly expressed rat and human histamine H3 receptors.
European journal of pharmacology 2002;453(1):33-41.
2000: Preben Olesen; Janne Tønder; J B Hansen; H C Hansen; Karin Rimvall
Bioisosteric replacement strategy for the synthesis of 1-azacyclic compounds with high affinity for the central nicotinic cholinergic receptors.
Bioorganic & medicinal chemistry 2000;8(6):1443-50.
1999: Janne Tønder; J B Hansen; M Begtrup; Ingrid Pettersson; Karin Rimvall; B Christensen; U Ehrbar; Preben Olesen
Improving the nicotinic pharmacophore with a series of (Isoxazole)methylene-1-azacyclic compounds: synthesis, structure-activity relationship, and molecular modeling.
Journal of medicinal chemistry 1999;42(24):4970-80.
1999: Lone Jeppesen; Preben Olesen; L Hansen; MJ Sheardown; C Thomsen; Thøger Rasmussen; A F Jensen; M S Christensen; Karin Rimvall; JS Ward; CA Whitesitt; David O Calligaro; Frank P Bymaster; Neil DeLapp; Christian Felder; Harlan E Shannon; Per Sauerberg
1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives.
Journal of medicinal chemistry 1999;42(11):1999-2006.
1998: Per Sauerberg; Lone Jeppesen; Preben Olesen; Thøger Rasmussen; MD Swedberg; MJ Sheardown; Anders Fink-Jensen; C Thomsen; H Thøgersen; Karin Rimvall; JS Ward; David O Calligaro; Neil DeLapp; Frank P Bymaster; Harlan E Shannon
Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity.
Journal of medicinal chemistry 1998;41(22):4378-84.
1998: Per Sauerberg; Lone Jeppesen; Preben Olesen; MJ Sheardown; Anders Fink-Jensen; Thøger Rasmussen; Karin Rimvall; Harlan E Shannon; Frank P Bymaster; Neil DeLapp; David O Calligaro; JS Ward; CA Whitesitt; C Thomsen
Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activation.
Bioorganic & medicinal chemistry letters 1998;8(20):2897-902.
1998: Preben Olesen; MD Swedberg; Karin Rimvall
3-(5-Alkylamino-4-isoxazolyl)-1,2,5,6-tetrahydropyridines: a novel class of central nicotinic receptor ligands.
Bioorganic & medicinal chemistry 1998;6(9):1623-9.
1998: Frank P Bymaster; Petra A Carter; Steven C Peters; Wei Zhang; JS Ward; Charles H Mitch; David O Calligaro; CA Whitesitt; Neil DeLapp; Harlan E Shannon; Karin Rimvall; Lone Jeppesen; MJ Sheardown; Anders Fink-Jensen; Per Sauerberg
Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.
Brain research 1998;795(1-2):179-90.
1998: GM Castillo; J A Cummings; W Yang; Martin Judge; MJ Sheardown; Karin Rimvall; J B Hansen; AD Snow
Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
Diabetes 1998;47(4):612-20.
1998: Per Sauerberg; Preben Olesen; MJ Sheardown; Karin Rimvall; H Thøgersen; Harlan E Shannon; BD Sawyer; JS Ward; Frank P Bymaster; Neil DeLapp; David O Calligaro; MD Swedberg
Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activity.
Journal of medicinal chemistry 1998;41(1):109-16.
1997: Harlan E Shannon; DE Womer; Frank P Bymaster; David O Calligaro; N C DeLapp; Charles H Mitch; JS Ward; CA Whitesitt; MD Swedberg; MJ Sheardown; Anders Fink-Jensen; Preben Olesen; Karin Rimvall; Per Sauerberg
In vivo pharmacology of butylthio[2.2.2] (LY297802 / NNC11-1053), an orally acting antinociceptive muscarinic agonist.
Life sciences 1997;60(13-14):969-76.